Kent Grindstaff

Doer
DISC Type : ds

Consulting Director at BioIVT

San Francisco Bay Area, United States

Overview

Kent is a seasoned life sciences R&D executive and current Consulting Director at BioIVT, with extensive experience in drug discovery, preclinical development, and operations. He holds a Ph. D. from Washington University in St. Louis and is recognized by colleagues for his insightful, hands-on, and science-driven perspective in advancing therapeutic programs from concept to IND-enabling status.

Based in Boise, Idaho, Kent is a key opinion leader in the application of New Approach Methodologies (NAMs) to replace, reduce, and refine animal use in drug development. He frequently speaks at industry events and contributes to publications on the topic, advocating for a coordinated approach to validate and standardize human-relevant alternatives.

He has an h-index of 15 and has been cited over 3, 400 times for his scientific publications.

Personality Overview

Long-term Focused

Deliberate Doer

Strategic Planner

Reading between the lines and seeing beyond your words comes naturally to them.  They are very professional in their approach and can weigh multiple perspectives together. They might take some time to make their mind up but once they do, they don't change it easily.

Topics They Care About

New Approach Methodologies (NAMs)
He is a vocal advocate for NAMs, recently speaking and writing about their practical application, validation, and role in meeting new FDA expectations.
Preclinical Development
A core focus of his career, he is interested in how advanced in vitro systems and computational approaches can improve the human relevance of preclinical models.
ADME-Tox Research
His work and presentations at BioIVT focus on ADME-Tox model systems, including hepatocytes and subcellular fractions, to better understand drug metabolism and safety.

Media Appearances

BioIVT Supports Non-CYP Metabolism Research with Hepatocyte Grants. Featured in Newswise

See Now

Work History

5-2025
Consulting Director at BioIVT
4-2023
Drug Discovery & Development at Innovra Consulting
1-2022 - 3-2023
SVP Research at CohBar, Inc.
6-2021 - 11-2021
SVP Discovery Research at BioAge Labs
5-2015 - 6-2021
VP Biology at CohBar, Inc.

Education

1989 - 1994
Ph.D. from Washington University in St. Louis
1985 - 1989
Bachelors of Arts from Knox College

More Information

Social Presence :

Prographics :

Exp : 30 Location : San Francisco Bay Area, United States Job Level : Mid-senior Designation : Consulting Director at BioIVT
URL has been copied!

Insights For Selling To Kent

During A Call Or A Meeting

DO's

  • Use phrases like 'your team deserves', 'best in class' etc.
  • Ask them at the end if they see a strong value prop in your product; expect an honest answer
  • During followups, use phone or text if needed, they should be fine

DONT's

  • Don't get into pricing discussions early on, steer conversation towards proven results
  • Don't take their patience for granted, avoid long-winding sermons
  • Don't go over them unless you are left with no other option

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Kent is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Kent

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Kent move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Kent take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Kent

Personality Compatibility


Other BioIVT Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.